Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04106219 |
|---|---|
| Brief Title: | A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma |
| First Submitted : | September 25, 2019 |
| First Submitted that Met QC Criteria : | September 25, 2019 |
| First Posted : | September 26, 2019 |
| Last Update Submitted that Met QC Criteria : | April 6, 2021 |
| Last Update Posted : | April 8, 2021 |